Prognostic significance of vascular endothelial growth factor protein levels in oral and oropharyngeal squamous cell carcinoma

被引:212
作者
Smith, BD
Smith, GL
Carter, D
Sasaki, CT
Haffty, BG
机构
[1] Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06520 USA
[2] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA
[3] Yale Univ, Sch Med, Dept Otolaryngol, New Haven, CT 06510 USA
关键词
D O I
10.1200/JCO.2000.18.10.2046
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Vascular Endothelial Growth factor (VEGF) promotes angiogenesis in many different tumor types, VEGF levels may affect tumor growth, metastatic potential, and response to radiotherapy. This study assesses the prognostic value of VEGF protein levels in a cohort of patients with oral and oropharyngeal squamous cell carcinomas, The relationships between clinical outcome and the covariables of tumor-node-metastasis stage, disease stage (I to IV), grade, margin status, race, sex, and age were also determined. Patients and Methods: Chart review identified 77 patients with oral or oropharyngeal squamous cell carcinoma treated with gross total surgical resection and postoperative radiation between 1981 and 1992, Sufficient follow-up data and tumor tissue were available in 56 patients (73%). VEGF protein levels were determined using immunohistochemistry. The association between VEGF status, covariables, and outcome was assessed in a bivariate and multivariate model using two-sided statistical tests. Results: Twenty-three tumors (41%) were positive for VEGF expression, VEGF-positive tumors were more likely to recur locally (relative risk [RR] = 3.08; 95% confidence interval [CI], 1.03 to 9.24) and distantly (RR = 4.62; 95% CI, 1.41 to 15.10), In bivariate analysis, VEGF positivity was the most significant predictor of poor disease-free survival (RR = 2.66; 95% CI, 1.27 to 5.56) and overall survival (RR = 3.21; 95% CI, 1.63 to 6.32). In multivariate analysis, VEGF positivity was the most significant predictor of poor disease-free survival (RR = 2.75; 95% CI, 1.30 to 5.79) and overall survival (RR = 3.53; 95% CI, 1.75 to 7.13). Conclusion: In this cohort, VEGF positivity was the most significant predictor of poor prognosis. VEGF status may prove to be an important prognostic factor in head and neck cancer, J Clin Oncol 18:2046-2052. (C) 2000 by American Society of Clinical Oncology.
引用
收藏
页码:2046 / 2052
页数:7
相关论文
共 43 条
  • [1] Akervall JA, 1997, CANCER, V79, P380
  • [2] *AM JOINT COMM CAN, 1992, MAN STAG CANC
  • [3] Bellacosa A, 1996, CLIN CANCER RES, V2, P175
  • [4] Artificial neural network model of survival in patients treated with irradiation with and without concurrent chemotherapy for advanced carcinoma of the head and neck
    Bryce, TJ
    Dewhirst, MW
    Floyd, CE
    Hars, V
    Brizel, DM
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1998, 41 (02): : 339 - 345
  • [5] Caminero MJ, 1996, ARCH OTOLARYNGOL, V122, P769
  • [6] EXPRESSION OF EPIDERMAL GROWTH-FACTOR RECEPTOR AND SURVIVAL IN UPPER AERODIGESTIVE TRACT CANCER
    DASSONVILLE, O
    FORMENTO, JL
    FRANCOUAL, M
    RAMAIOLI, A
    SANTINI, J
    SCHNEIDER, M
    DEMARD, F
    MILANO, G
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (10) : 1873 - 1878
  • [7] Denhart BC, 1997, LAB INVEST, V77, P659
  • [8] Eisma RJ, 1997, AM J SURG, V174, P513
  • [9] Markers of tumor angiogenesis and proteolysis independently define high- and low-risk subsets of node-negative breast cancer patients
    Eppenberger, U
    Kueng, W
    Schlaeppi, JM
    Roesel, JL
    Benz, C
    Mueller, H
    Matter, A
    Zuber, M
    Luescher, K
    Litschgi, M
    Schmitt, M
    Foekens, JA
    Eppenberger-Castori, S
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (09) : 3129 - 3136
  • [10] FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182